Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

saroglitazar MeSH Supplementary Concept Data 2025


MeSH Supplementary
saroglitazar
Unique ID
C000588741
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000588741
Entry Term(s)
(2S)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylsulfanyl)phenyl)-1H-pyrrol-1-yl(ethoxy)phenyl)propanoic acid
(2S)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylsulfanyl)phenyl)-1H-pyrrol-1-yl(ethoxy)phenyl)propanoic acid magnesium salt (2:1)
Lipaglyn
ZYH1 compound
alpha-ethoxy-4-(2-(2-methyl-5-(4-methylthio)phenyl))-1H-pyrrol-1-yl)ethoxy))benzenepropanoic acid
alpha-ethoxy-4-(2-(2-methyl-5-(4-methylthio)phenyl))-1H-pyrrol-1-yl)ethoxy))benzenepropanoic acid magnesium salt
saroglitazar magnesium
Registry Numbers
E0YMX3S4JD
0
K8V5DLS63R
Related Numbers
K8V5DLS63R
Heading Mapped to
*Phenylpropionates
*Pyrroles
Frequency
53
Note
a PPARalpha and PPARgamma agonist
Source
Clin Drug Investig. 2013 Nov;33(11):809-16.
Date of Entry
2014/06/04
Revision Date
2021/02/25
saroglitazar Preferred
alpha-ethoxy-4-(2-(2-methyl-5-(4-methylthio)phenyl))-1H-pyrrol-1-yl)ethoxy))benzenepropanoic acid Broader
ZYH1 compound Narrower
saroglitazar magnesium Narrower
page delivered in 0.005s